SEC Form 4 · accession 0001209191-15-032438

Acadia Healthcare Company, Inc. · ACHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Joey A Jacobs

Officer — Chief Executive Officer · Director · 10% Owner

Period of report

Apr 1, 2015

Accepted (ET)

Apr 3, 2015 · 5:46 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001520697

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Apr 1, 2015	S	9,023	$69.8899	D	325,020	D
Common Stock	Apr 2, 2015	M	8,831	$50.75	A	333,851	D
Common Stock	Apr 2, 2015	M	18,313	$15.96	A	352,164	D
Common Stock	Apr 2, 2015	M	16,650	$29.39	A	368,814	D
Common Stock	Apr 2, 2015	F	28,540	$70.20	D	340,274	D
Common Stock^F3	Apr 2, 2015	S	15,254	$70.156	D	325,020	D
Common Stock^F4,F5	holding	—	—		—	617,649	I	See Footnote

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option	$50.75	Apr 2, 2015	M	8,831	D	Feb 27, 2015	Feb 27, 2024	Common Stock	8,831	26,494	D
Stock Option	$15.96	Apr 2, 2015	M	18,313	D	Mar 19, 2014	Mar 19, 2022	Common Stock	18,313	18,315	D
Stock Option	$29.39	Apr 2, 2015	M	16,650	D	Mar 29, 2014	Mar 29, 2023	Common Stock	16,650	33,300	D

Explanation of responses

F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2014.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.1800 to $70.9600, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.7400 to $71.0000, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4Mr. Jacobs expressly disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
F5By the Jeremy Brent Jacobs GST Non-Exempt Trust u/a/d 04/26/2011 and Scott Douglas Jacobs GST Non-Exempt Trust u/a/d 04/26/2011.

Remarks

The reporting person is party to a stockholders agreement with Acadia Healthcare Company, Inc. ("Acadia") and certain other stockholders. As a result, he may be deemed to be a part of a "group" with such other stockholders. To the extent the reporting person is deemed a member of a group, he disclaims beneficial ownership of shares owned by other members of the group.